SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-030004
Filing Date
2020-10-30
Accepted
2020-10-30 19:47:34
Documents
2
Period of Report
2020-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3934
2 EX-24 DOCUMENT attachment1.htm EX-24 4675
  Complete submission text file 0000899243-20-030004.txt   10137
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CEREVEL THERAPEUTICS HOLDINGS INC. 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address
Bodenrader Mark (Reporting) CIK: 0001830371 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39311 | Film No.: 201278679